Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03428802
Brief Title: Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability

First Submitted : February 5, 2018
First Submitted that Met QC Criteria : February 5, 2018
First Posted : February 12, 2018

Last Update Submitted that Met QC Criteria : April 12, 2021
Last Update Posted : April 14, 2021